<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: reagents</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>New test may uncover deadly hypertension disease in pregnancy</title>
   	 <description>Collaborators at Cottage Health System and University of California, Santa Barbara (UCSB) have identified biomarkers that may yield a revolutionary diagnostic test for pre-eclampsia, a complex and potentially life-threatening hypertensive condition affecting 5% of pregnancies worldwide.</description>
     <link>http://medicalxpress.com/news/2012-10-uncover-deadly-hypertension-disease-pregnancy.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 22 Oct 2012 10:10:30 EST</pubDate>
	 <guid isPermaLink="false">news270119409</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newtestmayun.jpg" width="90" height="90" />
</item>
<item>
     <title>Endotoxemia influenced by diet type</title>
   	 <description>(HealthDay) -- A Western-style diet is associated with increased levels of endotoxin activity (endotoxemia), and a prudent-style diet (containing moderately greater amounts of omega-3 fatty acids, vitamin C, and vitamin E than the Western-style diet) is linked to reduced endotoxemia, according to a study published in the May issue of Gastroenterology.</description>
     <link>http://medicalxpress.com/news/2012-05-endotoxemia-diet.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 03 May 2012 14:50:07 EST</pubDate>
	 <guid isPermaLink="false">news255274618</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/endotoxemiai.jpg" width="90" height="98" />
</item>
<item>
     <title>Scientists use animal-free reagents to create clinical-grade neurons from skin cells</title>
   	 <description>(Medical Xpress) -- Using a specially designed facility, UCLA stem cell scientists have taken human skin cells, reprogrammed them into cells with the same unlimited property as embryonic stem cells, and then differentiated them into neurons while completely avoiding the use of animal-based reagents and feeder conditions throughout the process.</description>
     <link>http://medicalxpress.com/news/2011-12-scientists-animal-free-reagents-clinical-grade-neurons.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 09 Dec 2011 04:00:52 EST</pubDate>
	 <guid isPermaLink="false">news242625534</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/4-scientistsus.jpg" width="90" height="90" />
</item>
<item>
     <title>Novel approach to treat proliferative vitreoretinopathy shows promise</title>
   	 <description>Proliferative vitreoretinopathy (PVR), or the formation of scar tissue within the eye, is a serious, sight-threatening complication in patients recovering surgical repair of retinal detachment. A new study conducted by investigators at the Schepens Eye Research Institute, the Department of Ophthalmology at Harvard Medical School, and the Massachusetts Eye and Ear Infirmary in Boston, published in the December issue of the American Journal of Pathology, suggests that a cocktail containing reagents to neutralize a relatively small subset of vitreal growth factors and cytokines may be an effective treatment.</description>
     <link>http://medicalxpress.com/news/2011-10-approach-proliferative-vitreoretinopathy.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 31 Oct 2011 01:06:45 EST</pubDate>
	 <guid isPermaLink="false">news239241993</guid>
	 
</item>
<item>
     <title>FDA draft guidance document may limit patient access to tests</title>
   	 <description>The Association for Molecular Pathology (AMP) submitted comments to the US Food and Drug Administration on the draft guidance document titled, &quot;Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions.&quot; AMP is very concerned that this guidance could compromise the quality of patient care by severely reducing the availability of certain reagents and laboratory developed testing services that have become the standard of care for many diseases or conditions. Specifically, if enforced in its broadest sense without sufficient accommodations for low test volume or sufficient time for manufacturers to achieve submission compliance, the draft guidance document could result in reduced availability of testing services would limit a healthcare provider's ability to manage patient care, and ultimately limit patient access to new or improved molecular tests.</description>
     <link>http://medicalxpress.com/news/2011-08-fda-guidance-document-limit-patient.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 30 Aug 2011 11:40:52 EST</pubDate>
	 <guid isPermaLink="false">news233923187</guid>
	 
</item>
<item>
     <title>International effort mapping a pathway to generate renewable antibodies</title>
   	 <description>In the first study of its kind to date, an international group of scientists including Drs. Tony Pawson and Karen Colwill at Mount Sinai Hospital and Drs. Dev Sidhu and Aled Edwards at the University of Toronto have highlighted the power of renewable antibody technologies to create precise reagents for use in biomedical research -- a methodology that will help accelerate scientists' understanding of all the proteins coded in the human genome.</description>
     <link>http://medicalxpress.com/news/2011-05-international-effort-pathway-renewable-antibodies.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 17 May 2011 14:00:55 EST</pubDate>
	 <guid isPermaLink="false">news224859530</guid>
	 
</item>


</channel>
</rss>
